CLINICAL PROFILE OF DRUG-RESISTANT TUBERCULOSIS (DR-TB) PATIENTS DURING THE COVID-19 PANDEMIC AT RSUD DR. SOETOMO (JANUARY 2021 - DECEMBER 2021) (TITLE)
DOI:
https://doi.org/10.62567/micjo.v3i1.1608Keywords:
Tuberculosis, Drug-Resistant, COVID-19Abstract
The emergence of the COVID-19 pandemic in 2019 has had an impact on all aspects of life, particularly global health. Indonesia is one of the affected countries. The Indonesian government has responded to the conditions of this pandemic, one of which is by imposing access restrictions to prevent the pandemic from spreading. This policy indirectly affects the community's activities, including the utilization of existing healthcare services. Meanwhile, available data show that one of the major issues that the Indonesian state is still dealing with is its status as the third country with the greatest number of TB (Tuberculosis) cases in the world, with some of the TB cases being classified as Drug-Resistant Tuberculosis (DR-TB).
Downloads
References
Adiwinata, R., Rasidi, J., & Marpaung, M. (2018). Clinical Profile and Treatment Evaluation of Rifampicin-Resistant and Multidrug-Resistant Tuberculosis Patients at Dr. Kanujoso Djatiwibowo Public Hospital, Balikpapan. Jurnal Respirologi Indonesia, 38(3), 135-142.
Bhatia V., Mandal PP., Satyanarayana S., et al. Mitigating the impact of the COVID-19 pandemic on progress towards ending tuberculosis in the WHO South-East Asia Region. 2020. WHO South-East Asia journal of public health, 9(2), 95–99. https://doi.org/10.4103/2224-3151.294300
Duarte , R et al . 2018. Tuberculosis, social determinants and co-morbidities (including HIV). Rev Port Pulmonology.
McQuaid CF, Horton KC, Dean AS, Knight GM, White RG. The risk of multidrug- or rifampicin-resistance in males versus females with tuberculosis. Eur Respir J. 2020 Sep 17;56(3):2000626. doi: 10.1183/13993003.00626-2020. PMID: 32430421.
Global TB Caucus. Lembar Informasi-Dampak COVID-19 pada Layanan TB. McGill International TB Centre. 2021. https://www.mcgill.ca/tb/files/tb/COVID_tb_briefing_indo.pdf
Kant S., Tyagi R. The impact of COVID-19 on tuberculosis: challenges and opportunities. 2021. Therapeutic advances in infectious disease, 8, 20499361211016973. https://doi.org/10.1177/20499361211016973
Kementerian Kesehatan RI 2016, Tuberculosis: Temukan Obati Sampai Sembuh, Jakarta: Pusadatin.
WHO. 2020, Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug- Resistant Tuberculosis Treatment. Geneva, https://www.who.int/publications/i/item/97892400 07048 (2020).
WHO. Global Tuberculosis Report 2021. https://www.who.int/teams/global-tuberculosis-programme/data
WHO. Tuberculosis and COVID-19. 2020. https://www.who.int/docs/default-source/documents/tuberculosis/infonote-tb-COVID-19.pdf
WHO. WHO Coronavirus (COVID-19) Disease Indonesia. WHO Coronavirus (COVID-19) Disease Dashboard. 2020.
WHO. WHO Coronavirus (COVID-19) Disease Report. 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Valentina Alfianti Herdy Tamyn, Rebekah J. Setiabudi, Soedarsono, Ibrahim Syamsuri, Shofiuddin Al Mufid
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
